Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT04235634
Eligibility Criteria:
Inclusion Criteria:
\- persistent shock: Norepinephrine dose \> 0.2ug/kg/min over \> 48hrs
and
* intestinal failure: paralytic ileus \> 24hrs despite neostigmine therapy or
* new onset progressive organ failure (2 out of six criteria): Norepinephrine dose increase, rise in serum lactate, decrease in Horowitz index, new renal replacement therapy, rise in bilirubin, rise in INR, or all of the following: rise in ALT, AST, CK and LDH
Exclusion Criteria:
* patients \< 18 years old
* pregnancy
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04235634
Study Brief:
Protocol Section:
NCT04235634